Home › M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down
 

Keywords :   


M&A In Small-, Mid-Cap Biotechs Isn't Slowing Down

2015-12-14 20:08:05| Biotech - Topix.net

Michael Yee of RBC Capital Markets commented in a note that M&A activity within small- and mid-cap healthcare companies "doesn't seem to be slowing down much." Yee added that "good" late-stage and de-risked drugs should command a high value, regardless of any political uncertainty.

Tags: small slowing midcap biotechs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Durable Floor Coating from HMG Paints Transforms FC United\'s SMRE Bar
05.11Teknos Poland Honored by Farby i Lakiery
05.11Xumo teams up with Target to offer Hisense Xumo TVs
05.11KT launches 8K AI-powered IPTV set-top box
05.11Tropical Storm Rafael Graphics
More »